Tin tức & Cập nhật
Xem bài viết Bệnh nhiễm khuẩn
Xem
Chỉ hiển thị Multimedia

Dolutegravir knocks down HIV faster than bictegravir in French study
06 Oct 2026
bởiElvira Manzano
Final analysis of the BicDol study, presented at AIDS 2026, suggests that a first-line triple antiretroviral regimen containing dolutegravir suppresses HIV more rapidly than one containing bictegravir, particularly among patients with the highest viral loads.
06 Oct 2026

Switch from complex to single-tablet regimen does not compromise HIV suppression
01 Oct 2026
bởiStephen Padilla
Treatment with the single-tablet regimen (STR) doravirine/islatravir (DOR/ISL; 100/0.25 mg) results in sustained virologic suppression in almost all virologically suppressed adults with HIV-1 receiving complex antiretroviral therapy (ART) regimens, a study has shown.
01 Oct 2026






